UnitedHealth Group Incorporated $UNH Stake Decreased by Douglass Winthrop Advisors LLC

Douglass Winthrop Advisors LLC decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 87.8% in the 1st quarter, HoldingsChannel reports. The firm owned 11,688 shares of the healthcare conglomerate’s stock after selling 83,739 shares during the quarter. Douglass Winthrop Advisors LLC’s holdings in UnitedHealth Group were worth $6,122,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Ariston Services Group raised its stake in shares of UnitedHealth Group by 19.0% in the 1st quarter. Ariston Services Group now owns 839 shares of the healthcare conglomerate’s stock worth $439,000 after buying an additional 134 shares in the last quarter. AlphaQuest LLC raised its position in UnitedHealth Group by 237.9% in the first quarter. AlphaQuest LLC now owns 2,284 shares of the healthcare conglomerate’s stock worth $1,196,000 after acquiring an additional 1,608 shares in the last quarter. Fiduciary Management Inc. WI boosted its position in shares of UnitedHealth Group by 13.2% during the 1st quarter. Fiduciary Management Inc. WI now owns 472,710 shares of the healthcare conglomerate’s stock valued at $247,582,000 after purchasing an additional 55,086 shares in the last quarter. Leslie Global Wealth LLC bought a new stake in shares of UnitedHealth Group in the 1st quarter worth approximately $206,000. Finally, Strategies Wealth Advisors LLC bought a new stake in UnitedHealth Group during the first quarter worth approximately $527,000. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 1.2%

UnitedHealth Group stock opened at $307.0980 on Friday. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The company’s fifty day simple moving average is $288.39 and its 200-day simple moving average is $389.57. The stock has a market cap of $278.13 billion, a P/E ratio of 13.31, a P/E/G ratio of 1.96 and a beta of 0.43.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company’s quarterly revenue was up 12.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be given a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.9%. UnitedHealth Group’s payout ratio is currently 38.30%.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the company. Royal Bank Of Canada reduced their target price on UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a report on Wednesday, July 30th. Robert W. Baird reiterated an “underperform” rating and issued a $198.00 target price (down from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Wall Street Zen lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Saturday, May 24th. Wells Fargo & Company lowered their price objective on shares of UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating on the stock in a research report on Monday, August 4th. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating for the company in a research report on Wednesday, May 14th. Fifteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus price target of $365.38.

Insider Activity

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the firm’s stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer owned 10,398 shares of the company’s stock, valued at $3,171,390. This trade represents a 5.36% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 0.28% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.